Ingevity (NGVT)
(Delayed Data from NYSE)
$37.89 USD
-1.11 (-2.85%)
Updated Oct 1, 2024 04:00 PM ET
3-Hold of 5 3
B Value D Growth C Momentum C VGM
Ingevity (NGVT) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$48.60 | $58.00 | $40.00 | 28.27% |
Price Target
Based on short-term price targets offered by five analysts, the average price target for Ingevity comes to $48.60. The forecasts range from a low of $40.00 to a high of $58.00. The average price target represents an increase of 28.27% from the last closing price of $37.89.
Analyst Price Targets (5 )
Broker Rating
Ingevity currently has an average brokerage recommendation (ABR) of 1.80 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by five brokerage firms. The current ABR compares to an ABR of 2.00 a month ago based on six recommendations.
Of the five recommendations deriving the current ABR, three are Strong Buy, representing 60% of all recommendations. A month ago, Strong Buy represented 50%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 3 | 3 | 3 | 3 | 2 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 2 | 2 | 3 | 3 | 4 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.80 | 1.80 | 2.00 | 2.00 | 2.33 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
9/30/2024 | BMO Capital Markets | John P Mcnulty | Hold | Hold |
8/7/2024 | CJS Securities | Jonathan Tanwanteng | Hold | Strong Buy |
8/1/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
6/11/2024 | Wells Fargo Securities | Michael J Sison | Hold | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.80 |
ABR (Last week) | 1.80 |
# of Recs in ABR | 5 |
Average Target Price | $48.60 |
LT Growth Rate | NA |
Industry | Chemical - Specialty |
Industry Rank by ABR | 215 of 252 |
Current Quarter EPS Est: | 0.75 |
NGVT FAQs
Ingevity Corporation (NGVT) currently has an average brokerage recommendation (ABR) of 1.80 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 5 brokerage firms.
The average price target for Ingevity Corporation (NGVT) is $48.60. The current on short-term price targets is based on 2 reports.
The forecasts for Ingevity Corporation (NGVT) range from a low of $40 to a high of $58. The average price target represents a increase of $28.27 from the last closing price of $37.89.
The current UPSIDE for Ingevity Corporation (NGVT) is 28.27%
Based on short-term price targets offered by five analysts, the average price target for Ingevity comes to $48.60. The forecasts range from a low of $40.00 to a high of $58.00. The average price target represents an increase of 28.27% from the last closing price of $37.89.